be_ixf;ym_202111 d_28; ct_50
Loading Events

« All Events

  • This event has passed.

SARS-CoV-2: LabCorp CMO Update

April 7

Click Here to Access OnDemand Recording 

Click Here to Access CME Evaluation 

SARS-CoV-2: LabCorp CMO Update

Presented by:

Dorothy Adcock, MD

Chief Medical Officer, SVP | LabCorp of America

Learning Objectives: 

  • Describe the clinical significance of SARS-CoV-2 mutations
  • Explain the importance of the receptor biding domain of the SARS-CoV-2 virus
  • Discuss the likely origin of the SARS-CoV-2 pandemic

 

Dr Adcock is board certified in anatomic and clinical pathology. She earned her medical degree at Michigan State University and completed residency training in pathology at the University of Colorado.

Dr Adcock has worked as an anatomical and clinical pathologist and has spent the last 25 years focused on hemostasis testing. Her area of expertise is laboratory hemostasis with an emphasis on quality in laboratory medicine, pre-examination variables, clinical consultation, teaching, and standard setting.

Dr Adcock is a current chair of the FDA Hematology and Pathology Devices Panel. She is an appointed member of the American Board of Pathology Test Development and Advisory Committee and vice president of the North American Specialized Coagulation Laboratory Association. She serves on the College of American Pathologists (CAP) Phlebotomy Committee and is a previous member of the CAP Coagulation Resource Council. She chaired the CLSI committees on H21 (collection, transport, and processing of blood specimens for testing plasma-based coagulation assays) and H54 (procedures of validation of INR and local calibration of PT/INR systems). Dr Adcock is also a member of the American Society for Clinical Pathology and past president of the American Thrombosis Association.

Dr Adcock has authored more than 120 peer-reviewed publications, multiple book chapters, and numerous coagulation-based laboratory guidelines.

 

Accreditation Statement: The Beacon Health System is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.

Designation Statement: Beacon Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure: Physician(s) and all planners associated with this activity do not have any potential conflict of interest.

Disclosure Statement: As a CME provider accredited by the Indiana State Medical Association, Beacon Health System must ensure balance, independence, objectivity, and scientific rigor in all sponsored educational programs. All faculty participating in these programs must complete a disclosure statement indicating any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufactures, or other corporations whose products or services are related to the subject matter of the presentation topic.

Commercial Support: No commercial support was used in planning or implementation of the CME activity.

On Demand Details: Recordings are available for credit until 4/7/2022

Questions may be directed to Jenai White at 574.647.7691 or mewhite@beaconhealthsystem.org

Details

Date:
April 7
Event Categories:
, , ,